@hamza.alhomedy: احزان واصرار للشاعر #عبدالله_البردوني البردوني #حمزة_خالد_الحميدي #الجزائر_تونس_المغرب_الاماراات_مصر #اليمن

حمزة خالد الحميدي
حمزة خالد الحميدي
Open In TikTok:
Region: SA
Monday 31 August 2026 15:37:59 GMT
28725
1434
63
157

Music

Download

Comments

abdullah_alshamialyamany
عبدالله الشامي اليماني :
الله يرحم الشاعر اليمني الكبير عبد الله البردوني شاعر ومفكر ومؤرخ .👍
2026-09-01 16:06:45
1
mohmm1234567
الشاعر محمدالحرازي. :
عندي قصيدة يمكنك تلحينها جميلة جدا
2026-09-01 03:17:10
1
user677663755991
كان حلم :
الله ياروعه الكلمات واقعيه رحم الله البردوني
2026-09-01 04:37:30
3
embrator23
user8 الإمبراطور :
الرحمة والمغفرة والخلود لروحك الطيبة ♥️
2026-09-02 19:38:37
0
user1285455878102
خالد السقاف :
الله يرحمك يا بردوني عجزت النساء أن تلد شاعر بعدك
2026-09-02 11:15:11
0
fahedalshokani
fahedalshokani :
الله يرحمه رحمة الابرار
2026-09-01 20:26:43
0
neb7ras
نبراس المقبلي :
رحمه الله وأدخله فسيح جناته
2026-08-31 22:26:39
1
user29379159585163
مقرون مقرون :
رضي الله عنه ... شاعر اليمن وفيلسوفها الكبير ..البردوني ..
2026-08-31 15:57:14
0
wwwwww229
رونق :
❤️
2026-09-02 16:59:40
0
noonnoon5430
صقر قريش :
اللهم اغفرلعبد عبدالله البردوني اللهم ماكان بينك وبينه من ذنب فاغفره له وماكان بينه وبين عبادك فتحمله غنه واغفرله
2026-08-31 16:07:47
1
khaled.ali.almaskh
Khaled Ali Al-Maskhani :
الله يرحم الشاعر اليمني الكبير عبد الله البردوني شاعر ومفكر ومؤرخ .👍
2026-09-01 21:32:01
1
saba__246
ملكة سبأ :
الله يرحمه برحمته الواسعه
2026-09-01 19:44:56
0
hakeem.dakak
hakeem.dakak :
رحمة الله تغشاه كان لسان اليمن الذى اسكت كل شعراء عصره
2026-09-01 19:34:48
0
user2590935305879
آلَذِيَبً آلَيَمًآنِيَ :
رحمة ربي تغشاك بردوني
2026-09-02 00:46:54
0
freepalestine6978
freepalestine :
ابداع على ابد.اع على ابد.اع......كلمات ليست كالكلمات وصوت نادر بل ليس كالاصو ات.الله الله اللله على يمننا وما اهدانا.....
2026-09-02 00:09:01
0
mohmmedhasanmokbe
Mohmmed Hasan Mokbel :
الله الله
2026-09-01 19:37:14
0
o1rr2o
،🇾🇪البحر الاحمر اليمن🔥🇾🇪 :
الله يرحمه
2026-09-02 07:05:12
0
neb7ras
نبراس المقبلي :
والمرء لا تشقيه إلا نفسه... حاشا الحياة بأنها تشقيه
2026-08-31 22:27:07
1
mona.nasser72
Mona Nasser :
روووعه..
2026-09-01 03:54:24
0
user3686551906019
زيكو 💔 :
رحمة الله عليه
2026-09-01 18:30:08
0
user2034586877432
محمدعبدالمغني :
مبدع اليمن رحمه الله كلامه من ذهب
2026-09-01 18:06:25
0
dyok8owc5vp8
🌹عاشق🌹الورد🌹 :
:اللهم اغفرلعبد عبدالله البردوني اللهم ماكان بينك وبينه من ذنب فاغفره له وماكان بينه وبين عبادك فتحمله غنه واغفرله
2026-09-02 23:32:12
0
user6316096114537
متيم :
احسنت عشت
2026-09-01 13:37:13
0
noonnoon5430
صقر قريش :
اعطوه حقه وانشرو اشعاره فهو يستحق من ابنائه اليمنيين بره
2026-08-31 16:09:09
0
To see more videos from user @hamza.alhomedy, please go to the Tikwm homepage.

Other Videos

Survodutide might be WAY more interesting than just another weight-loss drug. 🧬🔥 Everyone is watching the scale. I’m watching the liver. Survodutide is an investigational dual GLP-1 + glucagon receptor agonist and the Phase 3 data are getting seriously interesting. In people with obesity and at-risk fatty liver disease (MASLD), 84.2% of participants receiving survodutide achieved at least a 30% reduction in liver fat at 48 weeks versus 24.3% with placebo. Even crazier? About 6 out of 10 reached liver fat levels below 5%.  And in the separate obesity trial, survodutide produced up to 16.6% average weight loss over 76 weeks.  But here’s what fascinates me. Survodutide isn’t simply making people eat less. We’re manipulating the same brain-gut-metabolic signaling network involved in hunger, satiety, energy balance and metabolic regulation. Preclinical research published this year showed survodutide activating brain regions involved in appetite regulation through its GLP-1 activity.  So maybe the bigger conversation isn’t: “How much weight can this drug make someone lose?” Maybe it’s: “Why was the metabolic system dysregulated enough to produce obesity and fatty liver in the first place?” The drugs are getting better. Now our understanding of the biology needs to get better too. 🔬 Educational purposes only. Not medical advice. Survodutide remains investigational, and these results should not be interpreted as establishing it as an approved treatment. #Survodutide #GLP1 #Glucagon #WeightLoss #Obesity
Survodutide might be WAY more interesting than just another weight-loss drug. 🧬🔥 Everyone is watching the scale. I’m watching the liver. Survodutide is an investigational dual GLP-1 + glucagon receptor agonist and the Phase 3 data are getting seriously interesting. In people with obesity and at-risk fatty liver disease (MASLD), 84.2% of participants receiving survodutide achieved at least a 30% reduction in liver fat at 48 weeks versus 24.3% with placebo. Even crazier? About 6 out of 10 reached liver fat levels below 5%. And in the separate obesity trial, survodutide produced up to 16.6% average weight loss over 76 weeks. But here’s what fascinates me. Survodutide isn’t simply making people eat less. We’re manipulating the same brain-gut-metabolic signaling network involved in hunger, satiety, energy balance and metabolic regulation. Preclinical research published this year showed survodutide activating brain regions involved in appetite regulation through its GLP-1 activity. So maybe the bigger conversation isn’t: “How much weight can this drug make someone lose?” Maybe it’s: “Why was the metabolic system dysregulated enough to produce obesity and fatty liver in the first place?” The drugs are getting better. Now our understanding of the biology needs to get better too. 🔬 Educational purposes only. Not medical advice. Survodutide remains investigational, and these results should not be interpreted as establishing it as an approved treatment. #Survodutide #GLP1 #Glucagon #WeightLoss #Obesity

About